The increase in E-cadherin expression, along with the inhibition of MMP-2/MMP-9 expression and thus of EMT, was also observed upon α-mangostin treatment in pancreatic cancer cell lines MIAPaCa-3 and BxPCa-2 [165]. The gene discussed is MMP9; the disease is familial pancreatic carcinoma.